157 related articles for article (PubMed ID: 37026312)
21. ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye.
Walter SD; Gronert K; McClellan AL; Levitt RC; Sarantopoulos KD; Galor A
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2472-8. PubMed ID: 27138739
[TBL] [Abstract][Full Text] [Related]
22. Comparison of mucin levels at the ocular surface of visual display terminal users with and without dry eye disease.
Duan H; Yang T; Zhou Y; Ma B; Zhao L; Chen J; Qi H
BMC Ophthalmol; 2023 Apr; 23(1):189. PubMed ID: 37106448
[TBL] [Abstract][Full Text] [Related]
23. Effect of Omega-3 on HLA-DR Expression by Conjunctival Cells and Tear Cytokine Concentrations in the Dry Eye Assessment and Management Study.
Roy NS; Yu Y; Ying GS; Maguire MG; Asbell PA;
Eye Contact Lens; 2022 Sep; 48(9):384-390. PubMed ID: 35916880
[TBL] [Abstract][Full Text] [Related]
24. Effects of tear hyperosmolarity on conjunctival cells in mild to moderate dry eye.
Julio G; Lluch S; Pujol P; Merindano MD
Ophthalmic Physiol Opt; 2012 Jul; 32(4):317-23. PubMed ID: 22620852
[TBL] [Abstract][Full Text] [Related]
25. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.
; Asbell PA; Maguire MG; Pistilli M; Ying GS; Szczotka-Flynn LB; Hardten DR; Lin MC; Shtein RM
N Engl J Med; 2018 May; 378(18):1681-1690. PubMed ID: 29652551
[TBL] [Abstract][Full Text] [Related]
26. Associations Between Systemic Omega-3 Fatty Acid Levels With Moderate-to-Severe Dry Eye Disease Signs and Symptoms at Baseline in the Dry Eye Assessment and Management Study.
Kuklinski EJ; Hom MM; Ying GS; Lin MC; Chapkin RS; Jones R; Moser A; Kim KY; Maguire MG; Asbell PA;
Eye Contact Lens; 2021 Jan; 47(1):2-7. PubMed ID: 32097181
[TBL] [Abstract][Full Text] [Related]
27. Red blood cell fatty acid analysis for determining compliance with omega3 supplements in dry eye disease trials.
Gadaria-Rathod N; Dentone PG; Peskin E; Maguire MG; Moser A; Asbell PA
J Ocul Pharmacol Ther; 2013 Nov; 29(9):837-41. PubMed ID: 23971620
[TBL] [Abstract][Full Text] [Related]
28. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
Benelli U; Nardi M; Posarelli C; Albert TG
Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
[TBL] [Abstract][Full Text] [Related]
29. Tear film changes in symptomatic versus asymptomatic video display terminal users following computer challenge test.
Srivastav S; Basu S; Singh S
Ocul Surf; 2023 Oct; 30():53-56. PubMed ID: 37595798
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
Christen WG; Cook NR; Manson JE; Buring JE; Lee IM; Bubes V; Friedenberg G; Dushkes R; Smith D; Schaumberg DA;
JAMA Ophthalmol; 2022 Jul; 140(7):707-714. PubMed ID: 35679030
[TBL] [Abstract][Full Text] [Related]
31. Safety and Efficacy of Oral Supplementation of Lentil (Lens culinaris Medic) in Dry Eye Patients.
Panahi Y; Roozbahani M; Pirhadi S; Aghamollaei H; Nejat F; Naderi M; Serahati S; Jadidi K; Sathyapalan T; Jamialahmadi T; Sahebkar A
Adv Exp Med Biol; 2021; 1328():377-384. PubMed ID: 34981490
[TBL] [Abstract][Full Text] [Related]
32. Video display terminal use and dry eye: preventive measures and future perspectives.
Kamøy B; Magno M; Nøland ST; Moe MC; Petrovski G; Vehof J; Utheim TP
Acta Ophthalmol; 2022 Nov; 100(7):723-739. PubMed ID: 35122403
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC
J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481
[TBL] [Abstract][Full Text] [Related]
34. Oral sea buckthorn oil attenuates tear film osmolarity and symptoms in individuals with dry eye.
Larmo PS; Järvinen RL; Setälä NL; Yang B; Viitanen MH; Engblom JR; Tahvonen RL; Kallio HP
J Nutr; 2010 Aug; 140(8):1462-8. PubMed ID: 20554904
[TBL] [Abstract][Full Text] [Related]
35. Association of Tear Osmolarity With Signs and Symptoms of Dry Eye Disease in the Dry Eye Assessment and Management (DREAM) Study.
Greiner JV; Ying GS; Pistilli M; Maguire MG; Asbell PA;
Invest Ophthalmol Vis Sci; 2023 Jan; 64(1):5. PubMed ID: 36626176
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of omega-3 fatty acids and punctal plugs in the prevention of isotretinoin-associated ocular surface disease.
Elhamaky TR
Eur J Ophthalmol; 2021 Sep; 31(5):2339-2345. PubMed ID: 32722939
[TBL] [Abstract][Full Text] [Related]
37. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye.
Kokke KH; Morris JA; Lawrenson JG
Cont Lens Anterior Eye; 2008 Jun; 31(3):141-6; quiz 170. PubMed ID: 18313350
[TBL] [Abstract][Full Text] [Related]
38. Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial.
Mohammadpour M; Mehrabi S; Hassanpoor N; Mirshahi R
J Curr Ophthalmol; 2017 Mar; 29(1):33-38. PubMed ID: 28367524
[TBL] [Abstract][Full Text] [Related]
39. Impact of upper blepharoplasty, with or without orbicularis oculi muscle removal, on tear film dynamics and dry eye symptoms: A randomized controlled trial.
Hollander MHJ; Pott JWR; Delli K; Vissink A; Schepers RH; Jansma J
Acta Ophthalmol; 2022 Aug; 100(5):564-571. PubMed ID: 34612583
[TBL] [Abstract][Full Text] [Related]
40. Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial.
Scuderi G; Contestabile MT; Gagliano C; Iacovello D; Scuderi L; Avitabile T
Can J Ophthalmol; 2012 Dec; 47(6):489-92. PubMed ID: 23217501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
